Target intelligence / Profile preview

MYL12B pseudogene 1 (MYL12BP1)

Target
MYL12BP1
Molecular classification
Other (pseudogene)
01

Overview

MYL12B pseudogene 1 (MYL12BP1) likely refers to a pseudogene of the MYL12B gene. Pseudogenes are genomic DNA sequences similar to normal genes but are generally non-functional, either due to mutations preventing their expression or because they do not encode functional proteins[6]. MYL12B itself is a protein-coding gene ("myosin light chain 12B, regulatory") involved in regulating the activity of nonmuscle myosin II via phosphorylation[2][3][5]. However, MYL12BP1 is not a characterized gene or therapeutic target in literature and is not associated with known protein product, molecular function, disease role, or interacting drugs. There is also no evidence to support its use as a biomarker or that it poses relevant safety concerns. Most resources, including genetic and protein databases, only document the protein-coding MYL12B and not MYL12BP1. The designation "pseudogene" indicates it is not a conventional target for drug development or disease intervention[6]. Key points: - MYL12BP1 is not a therapeutic target and does not encode a functional receptor, enzyme, transporter, or other protein product. - The entry is likely incorrect or not useful for target-based drug discovery; information about the actual functional gene should refer to MYL12B ("myosin light chain 12B, regulatory")[2][3][5]. - No functional data available: As a pseudogene, it does not participate in known biological functions, disease roles, or pharmacological mechanisms. If you are seeking information about the functional protein/gene, please refer to MYL12B (myosin light chain 12B, regulatory)[2][3][5]. If you specifically require information on the pseudogene, available data indicates it is non-functional and not a conventional drug target[6].

Other names
MYL12BP1MYL12B pseudogene

Beyond the preview

Go deeper on MYL12B pseudogene 1 (MYL12BP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MYL12B pseudogene 1 (MYL12BP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call